1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
hollywood1450@yahoo.ca
insider
Articles 

HealthCor Management, L.P. Buys Encompass Health Corp, ACADIA Pharmaceuticals Inc, Haemonetics Corp, Sells Regeneron Pharmaceuticals Inc, Johnson & Johnson, Hologic Inc

New York, NY, based Investment company HealthCor Management, L.P. (Current Portfolio) buys Encompass Health Corp, ACADIA Pharmaceuticals Inc, Haemonetics Corp, CVS Health Corp, Welltower Inc, sells Regeneron Pharmaceuticals Inc, Johnson & Johnson, Hologic Inc, HCA Healthcare Inc, Intersect ENT Inc during the 3-months ended 2020Q1, according to the most recent filings of the investment company, HealthCor Management, L.P.. As of 2020Q1, HealthCor Management, L.P. owns 46 stocks with a total value of $2.3 billion. These are the details of the buys and sells.

For the details of HealthCor Management, L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/healthcor+management%2C+l.p./current-portfolio/portfolio

These are the top 5 holdings of HealthCor Management, L.P.
  1. Nevro Corp (NVRO) - 1,752,620 shares, 7.49% of the total portfolio. Shares added by 49.79%
  2. Haemonetics Corp (HAE) - 1,438,356 shares, 6.13% of the total portfolio. Shares added by 166.88%
  3. Aurinia Pharmaceuticals Inc (AUPH) - 9,763,920 shares, 6.06% of the total portfolio. Shares added by 102.56%
  4. Laboratory Corp of America Holdings (LH) - 1,079,726 shares, 5.83% of the total portfolio. Shares added by 26.59%
  5. Neurocrine Biosciences Inc (NBIX) - 1,547,740 shares, 5.73% of the total portfolio. Shares added by 91.82%
New Purchase: Encompass Health Corp (EHC)

HealthCor Management, L.P. initiated holding in Encompass Health Corp. The purchase prices were between $50.07 and $82.81, with an estimated average price of $72.69. The stock is now traded at around $65.25. The impact to a portfolio due to this purchase was 4.18%. The holding were 1,525,809 shares as of .

New Purchase: ACADIA Pharmaceuticals Inc (ACAD)

HealthCor Management, L.P. initiated holding in ACADIA Pharmaceuticals Inc. The purchase prices were between $31.65 and $46.87, with an estimated average price of $41.34. The stock is now traded at around $50.11. The impact to a portfolio due to this purchase was 4.03%. The holding were 2,230,474 shares as of .

New Purchase: CVS Health Corp (CVS)

HealthCor Management, L.P. initiated holding in CVS Health Corp. The purchase prices were between $52.3 and $76.05, with an estimated average price of $67.09. The stock is now traded at around $62.44. The impact to a portfolio due to this purchase was 3.13%. The holding were 1,234,120 shares as of .

New Purchase: Welltower Inc (WELL)

HealthCor Management, L.P. initiated holding in Welltower Inc. The purchase prices were between $33.22 and $89.84, with an estimated average price of $74.34. The stock is now traded at around $40.33. The impact to a portfolio due to this purchase was 3.1%. The holding were 1,582,360 shares as of .

New Purchase: Bausch Health Companies Inc (BHC)

HealthCor Management, L.P. initiated holding in Bausch Health Companies Inc. The purchase prices were between $12.98 and $30.25, with an estimated average price of $24.35. The stock is now traded at around $15.80. The impact to a portfolio due to this purchase was 2.53%. The holding were 3,819,630 shares as of .

New Purchase: LivaNova PLC (LIVN)

HealthCor Management, L.P. initiated holding in LivaNova PLC. The purchase prices were between $34.22 and $76.49, with an estimated average price of $65.13. The stock is now traded at around $47.69. The impact to a portfolio due to this purchase was 2.37%. The holding were 1,225,890 shares as of .

Added: Haemonetics Corp (HAE)

HealthCor Management, L.P. added to a holding in Haemonetics Corp by 166.88%. The purchase prices were between $74.34 and $121.82, with an estimated average price of $108.81. The stock is now traded at around $99.80. The impact to a portfolio due to this purchase was 3.83%. The holding were 1,438,356 shares as of .

Added: Aurinia Pharmaceuticals Inc (AUPH)

HealthCor Management, L.P. added to a holding in Aurinia Pharmaceuticals Inc by 102.56%. The purchase prices were between $11.34 and $21.46, with an estimated average price of $17.73. The stock is now traded at around $17.03. The impact to a portfolio due to this purchase was 3.07%. The holding were 9,763,920 shares as of .

Added: Neurocrine Biosciences Inc (NBIX)

HealthCor Management, L.P. added to a holding in Neurocrine Biosciences Inc by 91.82%. The purchase prices were between $75.11 and $113.76, with an estimated average price of $98.22. The stock is now traded at around $116.08. The impact to a portfolio due to this purchase was 2.74%. The holding were 1,547,740 shares as of .

Added: Nevro Corp (NVRO)

HealthCor Management, L.P. added to a holding in Nevro Corp by 49.79%. The purchase prices were between $70.23 and $144.31, with an estimated average price of $120.56. The stock is now traded at around $117.81. The impact to a portfolio due to this purchase was 2.49%. The holding were 1,752,620 shares as of .

Added: Blueprint Medicines Corp (BPMC)

HealthCor Management, L.P. added to a holding in Blueprint Medicines Corp by 314.98%. The purchase prices were between $48.11 and $82.22, with an estimated average price of $64.89. The stock is now traded at around $63.38. The impact to a portfolio due to this purchase was 2.43%. The holding were 1,280,370 shares as of .

Added: Charles River Laboratories International Inc (CRL)

HealthCor Management, L.P. added to a holding in Charles River Laboratories International Inc by 234.07%. The purchase prices were between $98.9 and $178.34, with an estimated average price of $150.58. The stock is now traded at around $168.30. The impact to a portfolio due to this purchase was 2.21%. The holding were 584,620 shares as of .

Sold Out: Regeneron Pharmaceuticals Inc (REGN)

HealthCor Management, L.P. sold out a holding in Regeneron Pharmaceuticals Inc. The sale prices were between $336.18 and $494.43, with an estimated average price of $411.31.

Sold Out: Johnson & Johnson (JNJ)

HealthCor Management, L.P. sold out a holding in Johnson & Johnson. The sale prices were between $111.14 and $153.99, with an estimated average price of $142.18.

Sold Out: Intersect ENT Inc (XENT)

HealthCor Management, L.P. sold out a holding in Intersect ENT Inc. The sale prices were between $8.95 and $28.98, with an estimated average price of $22.35.

Sold Out: Danaher Corp (DHR)

HealthCor Management, L.P. sold out a holding in Danaher Corp. The sale prices were between $121.39 and $169.05, with an estimated average price of $152.42.

Sold Out: Intuitive Surgical Inc (ISRG)

HealthCor Management, L.P. sold out a holding in Intuitive Surgical Inc. The sale prices were between $367.75 and $618.29, with an estimated average price of $551.71.

Sold Out: Abiomed Inc (ABMD)

HealthCor Management, L.P. sold out a holding in Abiomed Inc. The sale prices were between $130.51 and $196.01, with an estimated average price of $166.33.



Here is the complete portfolio of HealthCor Management, L.P.. Also check out:

1. HealthCor Management, L.P.'s Undervalued Stocks
2. HealthCor Management, L.P.'s Top Growth Companies, and
3. HealthCor Management, L.P.'s High Yield stocks
4. Stocks that HealthCor Management, L.P. keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)